14

Apr

2015

Prime Therapeutics: Processing Update for Generic Adderall XR® for Covered Persons of Blue Cross Blue and Shield of Alabama

Effective: 5/1/2015

Effective May 1, 2015, generic Adderall XR® (Amphetamine-Methamphetamine SR) will not be covered by Blue Cross and Blue Shield of Alabama until multiple manufacturers become available or the price decreases. The innovator product Adderall XR® will remain on the Blue Cross formulary. Coverage of Adderall XR® will be dependent on the member’s benefit.

25

Mar

2015

Prime Therapeutics: REMINDER - Blue Cross Community MMAI offered by Blue Cross Blue Shield of Illinois

Effective: 3/1/2015 BIN: 011552 PCN: ILDEBM

Effective March 1, 2014, Prime Therapeutics (Prime) began processing Medicare Part D and Part B claims for Covered Persons of Blue Cross Community MMAI offered by Blue Cross Blue Shield of Illinois.

6

Mar

2015

Prime Therapeutics: Blue Cross and Blue Shield of Alabama - Concerta (Methylphenidate ER)

Claims Processing Update for Blue Cross and Blue Shield of Alabama Covered Persons

Effective March 1, 2015, Covered Persons of Blue Cross and Blue Shield of Alabama will experience higher co-pay or coinsurance costs with prescription claims for generic Concerta (Methylphenidate ER). This medication will cause the Covered Person’s co-pay or coinsurance to be greater than normal because it is considered to be a branded product and will process at a brand rate. Please see the attachment below for more information.
12